La Jolla, CA, United States of America

Carsten-Peter Carstens


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • San Diego, CA (US) (2007 - 2009)
  • La Jolla, CA (US) (2006 - 2020)

Company Filing History:


Years Active: 2006-2020

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Carsten-Peter Carstens

Introduction

Carsten-Peter Carstens is a prominent inventor based in La Jolla, California. With a total of 6 patents to his name, Carstens has made significant contributions to the field of biotechnology, particularly in the development of advanced techniques involving CRISPR and nucleic acid engineering.

Latest Patents

Among his notable inventions is a method of in vivo engineering of large sequences using multiple CRISPR/Cas selections of recombineering events. This innovative approach enables the creation of large nucleic acid sequences with defined compositions in living organisms. The method uniquely integrates recombineering techniques with the CRISPR/Cas system to facilitate the simultaneous insertion of multiple defined sequences into target nucleic acids, efficiently identifying successful recombinant cells through double-stranded cleavage of unsuccessful insertions. Additionally, he has developed a CAS9-based isothermal method for the detection of specific DNA sequences, further advancing the capabilities of nucleic acid detection in diverse samples.

Career Highlights

Throughout his career, Carsten-Peter Carstens has gained valuable experience working with leading biotechnology companies such as Stratagene California and Agilent Technologies, Inc. His expertise in the field has positioned him at the forefront of genetic engineering innovations, allowing for advancements that have potential applications in medicine, research, and beyond.

Collaborations

Carstens has collaborated with notable coworkers including Jeffrey Carl Braman and Natalia Novoradovskaya. These collaborations have fostered an environment of innovation and shared expertise, further driving the success of his projects and developments.

Conclusion

Carsten-Peter Carstens exemplifies the spirit of innovation within the biotechnology realm. His inventions, particularly in CRISPR technology and nucleic acid engineering, reflect a commitment to enhancing scientific knowledge and practical applications. As he continues to forge new paths in his field, his work promises to impact the landscape of genetic research and its applications for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…